United States · FDA National Drug Code directory
Memantine and Donepezil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-312_3d9a23dc-8cbe-47c3-a048-70d86cb9dc14
- Product NDC
- 33342-312
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Memantine and Donepezil
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250715
- Source listing expiry
- 20261231
Source-listed ingredients
- MEMANTINE HYDROCHLORIDE — 14 mg/1
- DONEPEZIL HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-312-07) · 33342-312-07
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-312-10) · 33342-312-10
- 10 BLISTER PACK in 1 CARTON (33342-312-12) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK · 33342-312-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →